Skip to main content
. 2019 Feb 1;8:25. doi: 10.1186/s13756-019-0475-9

Fig. 4.

Fig. 4

Trends of susceptibility to each antibiotic agent in the early (2007–2011) and late (2012–2016) periods of the study. Non-susceptibility to imipenem, piperacillin-tazobactam, cefepime, and trimethoprim-sulfamethoxazole increased in both ICU and non-ICU settings, while non-susceptibility to ciprofloxacin and ceftazidime increased in non-ICU settings but remained high in ICU settings. *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.0001